Longitudinal Evaluation of Visual Function Impairments in Early and Intermediate Age-Related Macular Degeneration Patients

• Published in: Ophthalmology science (Online) Vol. 2; no. 3; p. 100173
• Main Authors: Lad, Eleonora M, Fang, Vivienne, Tessier, Michel, Rautanen, Anna, Gayan, Javier, Stinnett, Sandra S, Luhmann, Ulrich F O
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier 01.09.2022
• Subjects: Early AMD; Intermediate AMD; LLVA; Microperimetry; Visual function; AREDS, Age-Related Eye Disease Study; RPD, reticular pseudodrusen; LLVA; MMRM, mixed-effect repeated measure; CFP, color fundus photography; Microperimetry; SD, standard deviation; AT, absolute threshold; PRT, percent reduced threshold; iAMD, intermediate AMD; LLVA, low-luminance visual acuity; HRF, hyperreflective foci; VF, visual function; Visual function; MP, microperimetry; eAMD, early AMD; CCT, cone contrast test; RPE, retinal pigment epithelium; AMD, age-related macular degeneration; RIT, rod intercept time; DA, dark adaptation; SD-OCT, spectral domain OCT; SNP, single nucleotide polymorphism; Early AMD; BCVA, best-corrected visual acuity; LLD, low-luminance deficit; Intermediate AMD; dB, decibels
• ISSN: 2666-9145; 2666-9145
• DOI: 10.1016/j.xops.2022.100173

To evaluate visual function (VF) changes in early and intermediate age-related macular degeneration (eAMD and iAMD) over 24 months. Prospective, observational natural history study. Participants were enrolled at the Duke Eye Center. A total of 101 subjects (33 with eAMD, 47 with iAMD, and 21 normal controls) were recruited. Visual function (VF) tests included best-corrected visual acuity (BCVA), low- luminance visual acuity (LLVA), microperimetry (MP), cone contrast tests (CCTs), and dark adaptation (DA). Mixed-effect model repeated measures based on absolute values and change from baseline identified VF tests differentiating AMD from controls and revealing longitudinal VF decline when controlling for covariates (baseline value, age, coronary artery disease, dry eye, and phakic status). Nine AMD genetic risk variants, combinations of these (genetic burden score), reticular pseudodrusen (RPD), and hyperreflective foci (HRF) were tested as predictors of diagnosis and VF performance. Longitudinal changes in VF metrics over 24 months. A total of 70 subjects completed the 2-year visit (22 with eAMD, 31 with iAMD, and 17 controls). Percent reduced threshold (PRT) on MP and CCT red significantly distinguished iAMD versus controls after 12 and 24 months, respectively. Cone contrast test red, PRT, and absolute threshold (AT) on MP showed significant longitudinal deterioration of VF in iAMD versus baseline at 12 months and onward, however, with a reduced rate of worsening. The DA data confirmed a preexisting functional deficit in iAMD at baseline and revealed an increasing proportion of poorly performing iAMD subjects in DA over the study period. None of the other VF measures showed consistent significant changes among the normal, early, and intermediate groups or over time. The genetic burden score was significantly associated with AMD diagnosis (relative risk for iAMD = 1.64,  < 0.01) and DA (  = 0.42,  = 0.00005). Reticular pseudodrusen and HRF showed moderate associations with DA and weak to moderate associations with MP variables. In iAMD, MP variables, CCT red, and DA revealed slow and nonlinear functional decline over 24 months. A structure-function relationship in eAMD and iAMD stages was demonstrated among HRF, RPD, and DA, possibly modified by genetic risk factors. These structural and functional features represent potential end points for clinical trials in iAMD.